Flow cytometry analysis revealed a significant increase in activated CD8+ (triple positive T cells: CD8+ CD25+ CD69+) cytotoxic T cells in FOXM1i and cisplatin treatment groups compared to control T cells cocultured with naïve and CR SCLC cells (Fig. 6D–F). This evidence concerns the gene CD69 and small cell lung carcinoma.